Jones Jeffrey Alan bought CGEM
February 22, 2024 · Form 4 insider transaction
Jones Jeffrey Alan bought 62,500 shares of Cullinan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
62,500
Price
$0.00
Total value
N/A
InsiderJones Jeffrey Alan
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 22, 2024
Filing dateFebruary 23, 2024
Shares owned after118,691
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the restricted stock unit vest on an annual basis over four years.